Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome

Abstract

SAMD9 and SAMD9L are two interferon-regulated genes located adjacent to each other on chromosome 7q21.2. Germline gain-of-function mutations in SAMD9/SAMD9L are the genetic cause of MIRAGE syndrome, ataxia pancytopenia syndrome (ATXPC), myeloid leukemia syndrome with monosomy 7 (MLSM7), refractory cytopenia of childhood (RCC), transient monosomy 7 in children, SAMD9L-associated autoinflammatory disease (SAAD) and a proportion of inherited aplastic anemia and bone marrow failure syndromes.